Literature DB >> 24720443

A Brief History of Biomedical Research Ethics in Iran: Conflict of Paradigms.

Kiarash Aramesh.   

Abstract

During the past two decades, Iran has experienced a noteworthy growth in its biomedical research sector. At the same time, ethical concerns and debates resulting from this burgeoning enterprise has led to increasing attention paid to biomedical ethics. In Iran, Biomedical research ethics and research oversight passed through major periods during the past decades, separated by a paradigm shift. Period 1, starting from the early 1970s, is characterized by research paternalism and complete reliance on researchers as virtuous and caring physicians. This approach was in concordance with the paternalistic clinical practice of physicians outside of research settings during the same period. Period 2, starting from the late 1990s, was partly due to revealing of ethical flaws that occurred in biomedical research in Iran. The regulatory and funding bodies concluded that it was not sufficient to rely solely on the personal and professional virtues of researchers to safeguard human subjects' rights and welfare. The necessity for independent oversight, emphasized by international declarations, became obvious and undeniable. This paradigm shift led to the establishment of research ethics committees throughout the country, the establishment of academic research centers focusing on medical ethics (MEHR) and the compilation of the first set of national ethical guidelines on biomedical research-one of the first and most important projects conducted by and in the MEHR. Although not yet arrived, 'period 3' is on its way. It is predictable from the obvious trends toward performance of high-quality clinical research and the appearance of a highly educated new generation, especially among women. Published 2014. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  Iran; biomedical research ethics; history; paradigm shift; research oversight

Mesh:

Substances:

Year:  2014        PMID: 24720443      PMCID: PMC4194183          DOI: 10.1111/dewb.12053

Source DB:  PubMed          Journal:  Dev World Bioeth        ISSN: 1471-8731            Impact factor:   2.294


  7 in total

1.  A bibliometric overview of 30 years of medical sciences productivity in iran.

Authors:  Hafez Mohammadhassanzadeh; Ali Samadikuchaksaraei; Farhad Shokraneh; Ali Valinejad; Hassan Abolghasem-Gorji; Chen Yue
Journal:  Arch Iran Med       Date:  2010-07       Impact factor: 1.354

2.  Strengthening medical ethics by strategic planning in the Islamic Republic of Iran.

Authors:  Bagher Larijani; Hossein Malek-Afzali; Farzaneh Zahedi; Elaheh Motevaseli
Journal:  Dev World Bioeth       Date:  2006-05       Impact factor: 2.294

3.  Emerging concerns about Iran's scientific and medical future.

Authors:  Gholamreza Habibi; Armin Rashidi; Marc D Feldman
Journal:  Lancet       Date:  2006-09-16       Impact factor: 79.321

4.  An Islamic view to stem cell research and cloning: Iran's experience.

Authors:  Kiarash Aramesh; Soroush Dabbagh
Journal:  Am J Bioeth       Date:  2007-02       Impact factor: 11.229

Review 5.  Contemporary medical ethics: an overview from Iran.

Authors:  Bagher Larijani; Farzaneh Zahedi
Journal:  Dev World Bioeth       Date:  2008-12       Impact factor: 2.294

6.  The influences of bioethics and Islamic jurisprudence on policy-making in Iran.

Authors:  Kiarash Aramesh
Journal:  Am J Bioeth       Date:  2007-10       Impact factor: 11.229

7.  Ethics and clinical research.

Authors:  H K Beecher
Journal:  N Engl J Med       Date:  1966-06-16       Impact factor: 91.245

  7 in total
  3 in total

Review 1.  Evolution of Iran's health research system over the past 50 years: a narrative review.

Authors:  Parisa Mansoori
Journal:  J Glob Health       Date:  2018-12       Impact factor: 4.413

2.  Sharing, reuse, and storage of biosamples among biomedical researchers in Jordan: Practice and concerns.

Authors:  Almuthanna K Alkaraki; Omar F Khabour; Karem H Alzoubi; Lina M K Al-Ebbini; Zaid Altaany
Journal:  PLoS One       Date:  2022-04-28       Impact factor: 3.240

3.  Continuing review of ethics in clinical trials: a surveillance study in Iran.

Authors:  Amin Mohamadi; Fariba Asghari; Arash Rashidian
Journal:  J Med Ethics Hist Med       Date:  2014-12-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.